References
1. Imazio M, Adler Y. Management of pericardial effusion. Eur
Heart J. 2013;34:1186-97.
2. Khandaker MH, Espinosa RE, Nishimura RA, et al. Pericardial disease:
diagnosis and management. Mayo Clin Proc. 2010;85(6):572-93.
3. Dybowska M, Kazanecka B, Kuca P, et al. Intrapericardial fibrinolysis
in purulent pericarditis-case report. Int J Emerg Med. 2015;8:36.
4. Cui HB, Chen XY, Cui CC, et al. Prevention of pericardial
constriction by transcatheter intrapericardial fibrinolysis with
urokinase. Chin Med Sci J. 2005;20:5-10.
5. Trivedi U, Fell C, Madsen JS, et al. Persistence and progression of
staphylococcal infection in the presence of public goods. Npj
Biofilms and Microbiomes . 2020;6:55.
6. Dybowska M, Szturmowicz M, Opoka L, et al. Intrapericardial
recombinant tissue plasminogen activator in purulent pericarditis- case
series. BMC Cardiovasc Disord. 2020;20:392.
7. Wiyeh AB, Ochodo EA, Wiysonge CS, et al. A systematic review of the
efficacy and safety of intrapericardial fibrinolysis in patients with
pericardial effusion. Int J Cardiol. 2018;250:223-228.
8. Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the
diagnosis and management of pericardial diseases: The Task Force for the
Diagnosis and Management of Pericardial Diseases of the European Society
of Cardiology (ESC) Endorsed by: The European Association for
Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36:2921-2964.
9. Augustin P, Desmard M, Mordant P, et al. Clinical review:
intrapericardial fibrinolysis in management of purulent
pericarditis. Crit Care. 2011;15:220.
10. Ustünsoy H, Celkan MA, Sivrikoz MC, et al. Intrapericardial
fibrinolytic therapy in purulent pericarditis. Eur J Cardiothorac
Surg. 2002;22(3):373-6.
11. Juneja R, Kothari SS, Saxena A, et al. Intrapericardial
streptokinase in purulent pericarditis. Arch Dis Child .
1999;80(3):275-7.
12. Ideh RC, Pollock L, Sanneh A, et al. Management of persistent
purulent pericarditis using streptokinase for intrapericardial
fibrinolysis. Paediatrics & International Child Health.2014;34(3):220-223.
13. Reznikoff CP, Fish JT, Coursin DB. Pericardial Infusion of Tissue
Plasminogen Activator in Fibropurulent Pericarditis. J Intensive
Care Med . 2003;18(1):47-51.
14. Schafer M, Lepori M, Delabays A, et al. Intrapericardial urokinase
irrigation and systemic corticosteroids: an alternative to
pericardectomy for persistent fibrino-purulent
pericarditis. Cardiovasc Surg . 2002;10(5):508-11.
15. Winkler WB, Karnik R, Slany J. Treatment of Exudative Fibrinous
Pericarditis with Intrapericardial Urokinase. The Lancet (British
Edition) . 1994;344(8936):1541-42.
16. Cross JH, De Giovanni JV, Silove ED. Use of streptokinase to aid in
drainage of postoperative pericardial effusion. Br Heart J .
1989;62(3):217-219.
17. Mann-Segal DD, Shanahan EA, Jones B, et al. Purulent
pericarditis: rediscovery of an old remedy. J Thorac Cardiovasc
Surg . 1996;111(2):487-8.
18. Defouilloy C, Meyer G, Slama M, et at. Intrapericardial
fibrinolysis: a useful treatment in the management of purulent
pericarditis. Intensive Care Med. 1997; 23: 117-118.
19. Tomkowski WZ, Gralec R, Kuca P, et al. Effectiveness of
Intrapericardial Administration of Streptokinase in Purulent
Pericarditis. Herz. 2004 ;29:802-805.
20. Abdelnabi M, Almaghraby A, Saleh Y, et al. Acute purulent
pericarditis treated conservatively with intrapericardial fibrinolysis
and intrapericardial and systemic antibiotics. Proc (Bayl Univ Med
Cent) . 2021;34(4):498-499.
21. Bigham MT, Brady PW, Manning PB, et al. Therapeutic application of
intrapericardial tissue plasminogen activator in a 4-month-old child
with complex fibropurulent pericarditis. Pediatr Crit Care
Med. 2008;9(1):e1-e4.
22. Ekim H. Demirbağ R. Intrapericardial Streptokinase for Purulent
Pericarditis. Surg Today . 2004;34:569-572.
23. Çakir Ö, Gurkan F, Balci AE, et al. Purulent Pericarditis in
Childhood: Ten Years of Experience. Journal of Pediatric Surgery .
2002;37(10):1404-08.